Apollo Endosurgery ROE 2025

Apollo Endosurgery Aktienanalyse

What does Apollo Endosurgery do?

Apollo Endosurgery Inc is a medical technology company based in Austin, Texas that specializes in minimally invasive surgical technologies and products. It was founded in 2005 and has since become one of the leading providers of endoscopic instruments and systems. The business model of Apollo Endosurgery is based on the development and marketing of innovative products for minimally invasive surgery. The company focuses on three main areas: bariatric surgery, gastrointestinal surgery, and endoscopic surgery. The goal is to provide patients with minimally invasive solutions that are less invasive, safer, and more effective than traditional surgical methods. In the field of bariatric surgery, Apollo Endosurgery offers a wide range of products for the treatment of obese patients. This includes the bioabsorbable Orbera gastric balloon system, which provides a non-surgical alternative for weight reduction. It is introduced endoscopically into the stomach and can reduce the volume of the stomach, resulting in a faster feeling of satiety. The system needs to be removed after six months, but studies have shown that it can lead to significant weight loss. In the gastrointestinal surgery sector, Apollo Endosurgery offers the OverStitch system for endoscopic sutures. This system allows for the safe and easy performance of sutures in hard-to-reach areas of the GI tract without the need for open surgery. The system can be used for a variety of applications, including the treatment of fistulas and sealing leaks in the esophagus and intestine. Apollo Endosurgery's endoscopic surgery division focuses on the development of instruments and systems for endoscopic procedures. This includes the OverStitch system, as well as the Flex-Endoflex system for endoscopic procedures in the biliary system. These products enable safer and more effective procedures. Overall, Apollo Endosurgery has developed a wide range of products for minimally invasive surgery, offering doctors and patients a variety of treatment options. The company has also evolved through acquisitions, such as the acquisition of the biopolymer-based Orbera system by Apollo Endosurgery Inc. The company has a strong international presence, operating in Europe, Asia, and the USA, and has numerous partners in these regions. It has established close relationships with key clinics and physicians and is actively involved in researching and developing new technologies for minimally invasive surgery. In conclusion, Apollo Endosurgery Inc is a leading medical technology company focused on the development of innovative products for minimally invasive surgery. The company offers a wide range of products for bariatric, gastrointestinal, and endoscopic surgery and has strong relationships with key clinics and physicians. Apollo Endosurgery has a strong international presence and consistently works on researching and developing new technologies to provide minimally invasive solutions for patients worldwide. Apollo Endosurgery ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Apollo Endosurgery's Return on Equity (ROE)

Apollo Endosurgery's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Apollo Endosurgery's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Apollo Endosurgery's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Apollo Endosurgery’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Apollo Endosurgery stock

What is the ROE (Return on Equity) of Apollo Endosurgery this year?

The ROE of Apollo Endosurgery this year is -1.22 undefined.

How has the Return on Equity (ROE) of Apollo Endosurgery developed compared to the previous year?

The ROE of Apollo Endosurgery has increased by 0% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Apollo Endosurgery?

A high ROE indicates that Apollo Endosurgery generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Apollo Endosurgery?

A low ROE can indicate that Apollo Endosurgery is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Apollo Endosurgery affect the company?

A change in ROE (Return on Equity) of Apollo Endosurgery can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Apollo Endosurgery?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Apollo Endosurgery?

Some factors that can influence Apollo Endosurgery's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Apollo Endosurgery pay?

Over the past 12 months, Apollo Endosurgery paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Apollo Endosurgery is expected to pay a dividend of 0 USD.

What is the dividend yield of Apollo Endosurgery?

The current dividend yield of Apollo Endosurgery is .

When does Apollo Endosurgery pay dividends?

Apollo Endosurgery pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Apollo Endosurgery?

Apollo Endosurgery paid dividends every year for the past 0 years.

What is the dividend of Apollo Endosurgery?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Apollo Endosurgery located?

Apollo Endosurgery is assigned to the 'Health' sector.

Wann musste ich die Aktien von Apollo Endosurgery kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Apollo Endosurgery from 7/13/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/13/2025.

When did Apollo Endosurgery pay the last dividend?

The last dividend was paid out on 7/13/2025.

What was the dividend of Apollo Endosurgery in the year 2024?

In the year 2024, Apollo Endosurgery distributed 0 USD as dividends.

In which currency does Apollo Endosurgery pay out the dividend?

The dividends of Apollo Endosurgery are distributed in USD.